Search Results 101-110 of 16332 for Gilbert's syndrome

  1. SX-682 Treatment in Subjects With Myelodysplastic Syndrome Who Had Disease Progression or Are Intolerant to Prior Therapy - Mayo Clinic

    The purpose of this study is to determine the safety profile, maximum tolerated dose (MTD), dose-limiting toxicities (DLT), and recommended Phase 2 dose (RP2D) ...

  2. Oncology (Medical) - Clinical trials

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory aggressive B- ...

  3. Overview - Irritable Bowel Syndrome Lab: Yuri A. Saito-Loftus - Mayo Clinic Research

    The Irritable Bowel Syndrome Lab aims to better understand the mechanisms underlying IBS to identify better diagnostic tests and treatments for patients.

  4. Hydroxocobalamin as a New and Possibly Superior Treatment for Refractory Vasoplegic Syndrome during Liver Transplant Surgery - Mayo Clinic

    The purpose of this study is to evaluate if Hydroxocobalamin may be a new and possibly superior treatment for refractory vasoplegic syndrome during liver ...

  5. A Study To Investigate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of RO7248824 In Participants With Angelman Syndrome - Mayo Clinic

    The primary objective of this study is to investigate the safety and tolerability of RO7248824 in participants with Angelman Syndrome (AS) aged 1-12 years.

  6. Overview - Alzheimer's Disease Research Center - Mayo Clinic Research

    The Mayo Clinic Alzheimer's Disease Research Center studies brain aging, Alzheimer's and related dementias. It provides support and resources to patients, ...

  7. Clinical trials - Oncology (Medical)

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory aggressive B- ...

  8. Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma - Mayo Clinic

    Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) will be non-randomly assigned to receive crizotinib added to current COG ...

  9. A Study of Long-term Symptom Improvement and Recurrence After Operative Management of Median Arcuate Ligament Syndrome - Mayo Clinic

    The purpose of this study is to evaluate long-term symptom resolution and quality of life improvements after operative management of median arcurate ligament ...

  10. A Study Using Chemotherapy to Treat Patients with Myelodysplastic Syndrome Before Donor Stem Cell Transplant - Mayo Clinic

    The purpose of this study is to see the effect of a chemotherapy treatment for patients with myelodysplastic syndrome before donor stem cell transplant. Giving ...